ANTX — AN2 THERAPEUTICS INC

Ownership history in PFIZER INC  ·  5 quarters on record

This page tracks every 13F SEC filing in which PFIZER INC reported a position in AN2 THERAPEUTICS INC (ANTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.34% (2025 Q4)
Avg. % of fund
0.18%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 715,295 — 0% 0.34% $815K $1.14
2025 Q3 UNCHANGED 715,295 — 0% 0.21% $908K $1.27
2025 Q2 UNCHANGED 715,295 — 0% 0.13% $758K $1.06
2025 Q1 UNCHANGED 715,295 — 0% 0.19% $972.8M $1.36
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ANTX price (monthly, adj. close)

Other funds also holding ANTX

As of 2025 Q4 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 0.52% Almitas Capital LLC 3Y 7Y 0.37% Rangeley Capital, LLC 0.06% LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.03% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% Woodline Partners LP 3Y 0.0% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% TWO SIGMA ADVISERS, LP 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% Valeo Financial Advisors, LLC 3Y 7Y 0.0%
← Back to PFIZER INC Holdings